An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
Successful anticancer immunotherapy should induce robust systemic immunity against metastases. Here, the authors engineer an inhalable nano-STING agonist, which synergizes with fractionated radiation to control lung metastases and confers long-term systemic antitumor immunity in mice.
Guardado en:
Autores principales: | Yang Liu, William N. Crowe, Lulu Wang, Yong Lu, W. Jeffrey Petty, Amyn A. Habib, Dawen Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/54ebf73015d9478d882dbc5a6522a5e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
por: Su Chul Jang, et al.
Publicado: (2021) -
Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection
por: Andrés Sanchez Alberti, et al.
Publicado: (2017) -
Carvacrol and PPARγ agonist, pioglitazone, affects inhaled paraquat-induced lung injury in rats
por: Fatemeh Amin, et al.
Publicado: (2021) -
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
por: Jiyu Zhou, et al.
Publicado: (2020) -
Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy
por: Aurélien Corroyer-Dulmont, et al.
Publicado: (2021)